Ispire Technology Inc. Reports Strong Financial Performance for 2024

Sep.27.2024
Ispire Technology Inc. Reports Strong Financial Performance for 2024
Ispire Technology Inc. (NASDAQ: ISPR) reported a record 31.4% revenue increase in their 2024 fiscal year performance.

According to PR Newswire on September 26th, Ispire (Ispire Technology Inc., NASDAQ trading code: ISPR) released its financial performance for the 2024 fiscal year ending on June 30th, 2024, and is submitting its annual report "Form 10-K" to the U.S. Securities and Exchange Commission (SEC) on September 26th.

 

Financial Performance in the 2024 Fiscal Year Shows:

 

  • Income increased by 31.4% year on year to $151.9 million, mainly driven by an increase in sales of American products, which rose from $41.6 million on June 30, 2023 to $63.1 million on June 30, 2024, an increase of $21.5 million; sales of European e-cigarette products increased by $6.5 million, from $58.8 million on June 30, 2023 to $65.3 million on June 30, 2024; sales of e-cigarette products in other markets increased by $5.7 million, from $3.0 million on June 30, 2023 to $6.0 million on June 30, 2024, primarily due to an increase in sales in South Africa to $5.4 million.
  • Gross profit increased by 43.3% from $20.8 million in the 2023 fiscal year to $29.8 million, with a gross margin increasing from 18.0% in 2023 to 19.6%. The increase was mainly due to changes in product mix, focusing on higher-margin products, improved economies of scale due to increased sales volume, and benefits from the company's manufacturing facility in Malaysia.
  • Total operating expenses increased by 73.0% from $25.3 million in the 2023 fiscal year to $43.7 million. This increase was mainly attributed to expenses related to supporting wages and contract labor, sales and marketing, professional fees, and increased stock-based compensation to expand the scope of operations.
  • The net loss was $14.8 million, compared to a net loss of $6.0 million in the 2023 fiscal year.
  • As of June 30, 2024, Ispire had $35.1 million in cash and cash equivalents, and $16.6 million in operating funds.

 

The company's CEO, Michael Wang, stated that...

 

In 2024, it was a foundational year for Ispire characterized by record-breaking revenue and significant profit margin expansion. It also laid the groundwork strategically for faster growth of our global nicotine business, with plans to focus our high-quality marijuana e-cigarette hardware on multi-state operator (MSO) clients.

 

We have established long-term strategic partnerships with industry leaders such as Acreage Holdings, Hidden Hills Club, Dank Pack, and the BRKFST brand collaborated with international singer Burna Boy, expanding market share and strengthening global operational infrastructure.

 

In addition, Ispire has established a 31,000 square feet modern production facility in Malaysia to tap into the international nicotine market, while also reducing costs and increasing profitability.

 

This spring, we successfully completed a $12.3 million initial public offering, strengthened our financial position, and laid the foundation for future international expansion.

 

We have also appointed a senior leadership team, with Jim McCormick as Chief Financial Officer, John Patterson as Senior Vice President of International Nicotine, and Dennis Lider as Senior Vice President of Marijuana E-cigarette Hardware Sales.

 

Ispire recently submitted its first PMTA application in four years for a disposable e-cigarette (ENDS) product with four flavors, marking our attempt to re-enter the U.S. e-cigarette market. The company is focused on driving innovation for growth, improving profit margins, and taking measures to restrict underage use of e-cigarette products, all while adhering to responsible marketing principles.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea’s Health Ministry says amendments to the Tobacco Business Act will take effect on April 24, bringing synthetic-nicotine e-liquid vapes under the legal definition of tobacco. The shift extends cigarette-style rules to these products, including mandatory graphic warnings, sharply limited advertising channels, stricter vending-machine placement requirements, and a ban on use in smoke-free areas, with enforcement checks slated from late April.
Feb.03 by 2FIRSTS.ai
New Nicotine Products Added to Tax List in Delaware Budget Proposal
New Nicotine Products Added to Tax List in Delaware Budget Proposal
Delaware Governor Matt Meyer’s proposed FY2027 budget would significantly raise cigarette and nicotine product taxes to help close a $500 million budget gap and generate new revenue. The cigarette tax would rise from $2.10 to $3.60 per pack, with increases on moist snuff, e-liquids and other tobacco products. Supporters say the move is justified, while small businesses warn of potential sales losses.
Feb.17
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
The Tobacco Board, under the administrative control of India’s Department of Commerce, has written to Finance Minister Nirmala Sitharaman (Nirmala Sitharaman) flagging the adverse impact of an “unprecedented” increase in cigarette excise duties on the industry and on millions of farmers and workers, and urging a revision of duty rates.
Feb.11 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11